Advertisement
Corrigendum| Volume 79, ISSUE 4, P488, December 2014

Download started.

Ok

Corrigendum to “Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene” [Maturitas 78 (2014) 212–218]

Published:November 03, 2014DOI:https://doi.org/10.1016/j.maturitas.2014.10.014
Corrigendum to “Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene” [Maturitas 78 (2014) 212–218]
Previous ArticleCorrigendum to: What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 78 (2014) 184–187
      The authors regret the article has the wrong NCT number on page 213, Table 1. The Table lists NCT00675688 as the SMART-2 trial but it should be NCT00234819 (http://clinicaltrials.gov/show/NCT00234819). NCT00675688 is the correct number for SMART-1.
      The authors would like to apologise for any inconvenience caused.

      Article info

      Publication history

      Published online: November 03, 2014

      Identification

      DOI: https://doi.org/10.1016/j.maturitas.2014.10.014

      Copyright

      © 2014 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX